Inhibrx Biosciences Inc [NASDAQ: INBX] gained 1.19% or 0.98 points to close at $83.66 with a heavy trading volume of 145974 shares.
It opened the trading session at $82.7, the shares rose to $84.34 and dropped to $80.17, the range by which the price of stock traded the whole day. The daily chart for INBX points out that the company has recorded 508.44% gains over the past six months.
If we look at the average trading volume of 355.28K shares, INBX reached to a volume of 145974 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Inhibrx Biosciences Inc [INBX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for INBX shares is $12.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on INBX stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JMP Securities have made an estimate for Inhibrx Biosciences Inc shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on July 23, 2024.
The Price to Book ratio for the last quarter was 32.93, with the Price to Cash per share for the same quarter was set at 10.53.
Trading performance analysis for INBX stock
Inhibrx Biosciences Inc [INBX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.85. With this latest performance, INBX shares gained by 22.15% in over the last four-week period, additionally plugging by 508.44% over the last 6 months – not to mention a rise of 443.25% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for INBX stock in for the last two-week period is set at 68.36, with the RSI for the last a single of trading hit 6.53, and the three-weeks RSI is set at 6.02 for Inhibrx Biosciences Inc [INBX]. The present Moving Average for the last 50 days of trading for this stock 54.41, while it was recorded at 82.22 for the last single week of trading, and 26.37 for the last 200 days.
Inhibrx Biosciences Inc [INBX]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Inhibrx Biosciences Inc [INBX] shares currently have an operating margin of -11002.14% and a Gross Margin at -86.29%. Inhibrx Biosciences Inc’s Net Margin is presently recorded at -11077.57%.
Inhibrx Biosciences Inc (INBX) Capital Structure & Debt Analysis
According to recent financial data for Inhibrx Biosciences Inc. ( INBX), the Return on Equity (ROE) stands at -144.07%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -77.54%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Inhibrx Biosciences Inc’s Return on Invested Capital (ROIC) is -109.61%, showcasing its effectiveness in deploying capital for earnings.
Inhibrx Biosciences Inc (INBX) Efficiency & Liquidity Metrics
Based on Inhibrx Biosciences Inc’s (INBX) latest financial statements, the Debt-to-Equity Ratio is 2.90%, indicating its reliance on debt financing relative to shareholder equity.
Inhibrx Biosciences Inc (INBX) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Inhibrx Biosciences Inc. (INBX) effectively leverages its workforce, generating an average of -$963291.93 per employee. The company’s liquidity position is robust, with a Current Ratio of 4.49% and a Quick Ratio of 4.49%, indicating strong ability to cover short-term liabilities.
An analysis of Institutional ownership at Inhibrx Biosciences Inc [INBX]
There are presently around $63.36%, or 86.87%% of INBX stock, in the hands of institutional investors. The top three institutional holders of INBX stocks are: VIKING GLOBAL INVESTORS LP with ownership of 1.79 million shares, which is approximately 12.3495%. PERCEPTIVE ADVISORS LLC, holding 1.06 million shares of the stock with an approximate value of $$15.08 million in INBX stocks shares; and PERCEPTIVE ADVISORS LLC, currently with $$9.68 million in INBX stock with ownership which is approximately 4.7187%.
